ICH Steering Committee to Meet in Japan

News
Article

The ICH Steering Committee will meet from June 6–11, 2015 to discuss a variety of harmonization topics.

 

The International Conference on Harmonization’s (ICH’s) ICH Week will occur from June 6–11, 2015 in Fukuoka, Japan, where a variety of harmonization topics affecting the pharmaceutical industry will be discussed. The week’s agenda includes a session on global cooperation, a meeting of the ICH Medical Dictionary for Regulatory Activities (MedDRA) Management Board, the International Pharmaceutical Regulators Forum, as well as meetings involving ICH technical working groups.

Included in the discussions will be status updates on the implementation of ICH guidelines. Among the guidelines to be addressed are:

·       S5(R3) Revision of Detection of Toxicity to Reproduction for Medicinal Products and Toxicity to Male Fertility

·       S11 ICH Guideline on Nonclinical Safety Testing in support of Development of Paediatric Medicines

·       Q12 Guideline on Life Cycle Management

·       E11(R1) Addendum to Paediatric Drug Development

·       E18 ICH Guideline on Genomic Sampling Methodologies for Future Use

·       M2 Electronic Standards for the Transfer of Regulatory Information

·       M8 The Electronic Common Technical Document: eCTD.

The week will also include a membership update and the discussion and organization of ICH training activities. The full agenda can be found on ICH’s website

Source: ICH.org

Recent Videos
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.